For years, the use of polyhistidine
tags (His-tags) has been a
staple in the isolation of recombinant proteins in immobilized metal
affinity chromatography experiments. Their usage has been widely beneficial
in increasing protein purity from crude cell lysates. For some recombinant
proteins, a consequence of His-tag addition is that it can affect
protein function and stability. Functional proteins are essential
in the elucidation of their biological, kinetic, structural, and thermodynamic
properties. In this study, we determine the effect of N-terminal His-tags
on the thermal stability of select proteins using differential scanning
fluorimetry and identify that the removal of the His-tag can have
both beneficial and deleterious effects on their stability.
Der p 2 is one of the most important allergens from the house dust mite Dermatophagoides pteronyssinus. Identification of human IgE Ab binding epitopes can be used for rational design of allergens with reduced IgE reactivity for therapy. Antigenic analysis of Der p 2 was performed by site-directed mutagenesis based on the x-ray crystal structure of the allergen in complex with a Fab from the murine IgG mAb 7A1 that binds an epitope overlapping with human IgE binding sites. Conformational changes upon Ab binding were confirmed by nuclear magnetic resonance using a 7A1-single-chain variable fragment. In addition, a human IgE Ab construct that interferes with mAb 7A1 binding was isolated from a combinatorial phage-display library constructed from a mite-allergic patient and expressed as two recombinant forms (single-chain Fab in Pichia pastoris and Fab in Escherichia coli). These two IgE Ab constructs and the mAb 7A1 failed to recognize two Der p 2 epitope double mutants designed to abolish the allergen-Ab interaction while preserving the fold necessary to bind Abs at other sites of the allergen surface. A 10-100-fold reduction in binding of IgE from allergic subjects to the mutants additionally showed that the residues mutated were involved in IgE Ab binding. In summary, mutagenesis of a Der p 2 epitope defined by x-ray crystallography revealed an IgE Ab binding site that will be considered for the design of hypoallergens for immunotherapy.
Der p 1 is a major allergen from the house dust mite Dermatophagoides pteronyssinus that belongs to the papain-like cysteine protease family. To investigate the antigenic determinants of Der p 1, we determined two crystal structures of Der p 1 in complex with the Fab fragments of mAbs 5H8 or 10B9. Epitopes for these two Der p 1-specific antibodies are located in different, non-overlapping parts of the Der p 1 molecule. Nevertheless, surface area and identity of the amino acid residues involved in hydrogen bonds between allergen and antibody are similar. The epitope for mAb 10B9 only, showed a partial overlap with the previously reported epitope for mAb 4C1, a cross-reactive mAb that binds Der p 1 and its homolog Der f 1 from D. farinae. Upon binding to Der p 1, the Fab fragment of mAb 10B9 was found to form a very rare alpha-helix in its third CDR of the heavy chain. In order to provide an overview of the surface properties of the interfaces formed by the complexes of Der p 1-10B9 and Der p 1-5H8, along with the complexes of 4C1 with Der p 1 and Der f 1, a broad analysis of the surfaces and hydrogen bonds of all complexes of Fab-protein or Fab-peptide was performed. This work provides detailed insight into the cross-reactive and specific allergen-antibody interactions in Group 1 mite allergens. The surface data of Fab-protein and Fab-peptide interfaces can be used in the design of less potent conformational epitopes for immunotherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.